Literature DB >> 33345653

Soluble Flt1 levels are associated with cardiac dysfunction in Black women with and without severe preeclampsia.

Lisa Levine1, Zolt Arany2,3, Adina Kern-Goldberger1, Nathanael Koelper4, Jennifer Lewey3, Mary D Sammel5, Michal A Elovitz1, Bonnie Ky2,3,6.   

Abstract

Background: We evaluate soluble fms-like tyrosine kinase-1 (sFlt-1) levels and cardiac function during pregnancy and postpartum among Black women with and without preeclampsia. Study design: Prospective longitudinal cohort study from 2015 to 2017 of Black women with preterm severe preeclampsia and normotensive pregnant controls.We obtained echocardiograms and sFlt-1 levels during pregnancy and postpartum.
Results: 93 Black women were included (43 cases, 50 controls). Higher sFlt1 levels were correlated with worse longitudinal strain, diastolic dysfunction, decreased ventricular-arterial coupling, and increased chamber and arterial elastance at the time of preeclampsia diagnosis and postpartum. Conclusions: Higher sFlt1 levels are associated with cardiovascular dysfunction during pregnancy and postpartum.

Entities:  

Keywords:  Black women; cardiac function; echocardiogram; longitudinal strain; preeclampsia; soluble Flt

Mesh:

Substances:

Year:  2020        PMID: 33345653      PMCID: PMC7856576          DOI: 10.1080/10641955.2020.1861462

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  21 in total

1.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kosha Ruparel; Nancy K Sweitzer; James C Fang; Wayne C Levy; Douglas B Sawyer; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

3.  Differences in preeclampsia rates between African American and Caucasian women: trends from the National Hospital Discharge Survey.

Authors:  Khadijah Breathett; David Muhlestein; Randi Foraker; Martha Gulati
Journal:  J Womens Health (Larchmt)       Date:  2014-09-11       Impact factor: 2.681

4.  Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.

Authors:  Lori Mosca; Emelia J Benjamin; Kathy Berra; Judy L Bezanson; Rowena J Dolor; Donald M Lloyd-Jones; L Kristin Newby; Ileana L Piña; Véronique L Roger; Leslee J Shaw; Dong Zhao; Theresa M Beckie; Cheryl Bushnell; Jeanine D'Armiento; Penny M Kris-Etherton; Jing Fang; Theodore G Ganiats; Antoinette S Gomes; Clarisa R Gracia; Constance K Haan; Elizabeth A Jackson; Debra R Judelson; Ellie Kelepouris; Carl J Lavie; Anne Moore; Nancy A Nussmeier; Elizabeth Ofili; Suzanne Oparil; Pamela Ouyang; Vivian W Pinn; Katherine Sherif; Sidney C Smith; George Sopko; Nisha Chandra-Strobos; Elaine M Urbina; Viola Vaccarino; Nanette K Wenger
Journal:  Circulation       Date:  2011-02-14       Impact factor: 29.690

5.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia.

Authors:  Sajid Shahul; Avery Tung; Mohammed Minhaj; Junaid Nizamuddin; Julia Wenger; Eitezaz Mahmood; Ariel Mueller; Shahzad Shaefi; Barbara Scavone; Robb D Kociol; Daniel Talmor; Sarosh Rana
Journal:  Hypertens Pregnancy       Date:  2015-12-04       Impact factor: 2.108

7.  Circulating Antiangiogenic Factors and Myocardial Dysfunction in Hypertensive Disorders of Pregnancy.

Authors:  Sajid Shahul; Diego Medvedofsky; Julia B Wenger; Junaid Nizamuddin; Samuel M Brown; Surichhya Bajracharya; Saira Salahuddin; Ravi Thadhani; Ariel Mueller; Avery Tung; Roberto M Lang; Zoltan Arany; Daniel Talmor; S Ananth Karumanchi; Sarosh Rana
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

Review 8.  Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Theresa M Beckie; Holli A DeVon; Cindy L Grines; Harlan M Krumholz; Michelle N Johnson; Kathryn J Lindley; Viola Vaccarino; Tracy Y Wang; Karol E Watson; Nanette K Wenger
Journal:  Circulation       Date:  2016-01-25       Impact factor: 29.690

Review 9.  Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.

Authors:  Camille E Powe; Richard J Levine; S Ananth Karumanchi
Journal:  Circulation       Date:  2011-06-21       Impact factor: 29.690

10.  Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.

Authors:  Ian S Patten; Sarosh Rana; Sajid Shahul; Glenn C Rowe; Cholsoon Jang; Laura Liu; Michele R Hacker; Julie S Rhee; John Mitchell; Feroze Mahmood; Philip Hess; Caitlin Farrell; Nicole Koulisis; Eliyahu V Khankin; Suzanne D Burke; Igor Tudorache; Johann Bauersachs; Federica del Monte; Denise Hilfiker-Kleiner; S Ananth Karumanchi; Zoltan Arany
Journal:  Nature       Date:  2012-05-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.